Virus-host interactions in paediatric HIV-1 infection

Current Opinion in HIV and AIDS

Volumn 2, Issue 5, 2007, Pages 399-404

  De Rossi, Anita ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b AIDS Reference Center   (Italy)

Author keywords

Genetic host factors; HIV 1 variability; Paediatric HIV 1 infection

Indexed keywords

ANTIVIRAL ACTIVITY; DISEASE COURSE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFECTION PREVENTION; INNATE IMMUNITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS GENE; VIRUS TRANSMISSION;

EID: 34547925292     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3282ced163     Document Type: Review

References (30)

1. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-465.
2. Dunn D, HIV Paediatric Prognostic Markers Collaborative Study Group. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003; 362:1605-1611.
3. Little K, Thorne C, Luo C, et al. Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res 2007; 5:139-153.
4. Zanchetta M, Walker S, Burighel N, et al. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy. J Infect Dis 2006; 193:1718-1727.
5. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999; 341:385-393.
6. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999; 341:394-402.
7. European Collaborative Study. Maternal viral load and vertical transmission of HIV: an important factor but not the only one. AIDS 1999; 13:1377-1385.
8. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007; 369:1107-1116. This study, performed in a large cohort of infants born to HIV-1-infected mothers, demonstrated that exclusive breastfeeding is associated with a lower risk of MTCT than other types of infant feeding.
9. Phiri W, Kasonka L, Collins S, et al. Factors influencing breast milk HIV RNA viral load among Zambian women. AIDS Res Hum Retroviruses 2006; 22:607-614.
10. Renjifo B, Gilbert P, Chaplin B, et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 2004; 18:1629-1636.
11. Yang C, Li M, Newman RD, et al. Genetic diversity of HIV-1 in western Kenya. Subtype-specific differences in mother-to-child transmission. AIDS 2003; 11:1667-1674.
12. Koulinska IN, Villamor E, Msamanga G, et al. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and nonrecombinant HIV-1 genotypes. Virus Res 2006; 120:191-198.
13. Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 co-receptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 2004; 20:111-126.
14. Salvatori F, Masiero S, Giaquinto C, et al. Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol 1997; 71:4694-4706.
15. Ometto L, Zanchetta M, Mainardi M, et al. Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS 2000; 14:1721-1729.
16. Peters PJ, Sullivan WM, Duenas-Decamp MJ, et al. Nonmacrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis. J Virol 2006; 80:6324-6332.
17. Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. Eur J Paediatr Neurol 2007; 11:1-9.
18. Gray GE, Urban M, Chersich MF, et al. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 2005; 19:1289-1297.
19. Roques PA, Gras G, Parnet MF, et al. Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 1995; 9:F19-F26.
20. Newell ML, Dunn D, De Maria A, et al. Detection of virus in vertically exposed HIV-antibody negative children. Lancet 1996; 347:213-215.
21. Vazquez Perez JA, Basualdo Sigales MC, Reyes-Teran G, et al. Human immunodeficiency virus type 1 in seronegative infants born to HIV-1-infected mothers. Virol J 2006; 3:52-57.
22. Ruprecht RM, Baba TW, Rasmussen R, et al. Murine and simian retrovirus models: the threshold hypothesis. AIDS 1996; 10 (Suppl A):S33-S40.
23. Schramm DB, Meddows-Taylor S, Gray GE, et al. Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses. Clin Vaccine Immunol 2007; 14:348-354.
24. Lohman BL, Slyker JA, Richardson BA, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol 2005; 79:8121-8130.
25. Luzuriaga K, McManus M, Catalina M, et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1 specific immune responses. J Virol 2000; 74:6984-6991.
26. De Rossi A. Primary HIV infection in infants: impact of highly active antiretroviral therapy on the natural course. J Biol Regul Homeost Agents 2002; 16:53-57.
27. Blanche S, Newell ML, Mayaux MJ, et al. Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:442-450.
28. Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994; 343:191-195.
29. De Rossi A, Masiero S, Giaquinto C, et al. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 1996; 97:323-330.
30. European Collaborative Study. Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected children. AIDS 2004; 18:509-516.